000 01428 a2200313 4500
005 20250517154218.0
264 0 _c20180914
008 201809s 0 0 eng d
022 _a1435-4373
024 7 _a10.1007/s10096-017-3010-z
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGiacobbe, D R
245 0 0 _aPitfalls of defining combination therapy for carbapenem-resistant Enterobacteriaceae in observational studies.
_h[electronic resource]
260 _bEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology
_c10 2017
300 _a1707-1709 p.
_bdigital
500 _aPublication Type: Editorial
650 0 4 _aAnti-Bacterial Agents
_xpharmacology
650 0 4 _aCarbapenem-Resistant Enterobacteriaceae
_xdrug effects
650 0 4 _aDrug Therapy, Combination
650 0 4 _aEnterobacteriaceae Infections
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aObservational Studies as Topic
650 0 4 _aRandomized Controlled Trials as Topic
650 0 4 _abeta-Lactam Resistance
_xdrug effects
700 1 _aMaraolo, A E
700 1 _aViscoli, C
773 0 _tEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology
_gvol. 36
_gno. 10
_gp. 1707-1709
856 4 0 _uhttps://doi.org/10.1007/s10096-017-3010-z
_zAvailable from publisher's website
999 _c27194908
_d27194908